Trends in internet searches for cannabidiol (CBD) in the United States

Abstract

Cannabidiol (CBD) is widely promoted as a panacea. For example, the cannabis brand MedMen claims CBD treats acne, anxiety, opioid addiction, pain, and menstrual problems.1 However, the US Food and Drug Administration has only approved highly purified CBD (Epidiolex) for treating epilepsy. To our knowledge, there is currently no population-focused surveillance of public interest in CBD. Consequently, many question whether CBD should be prioritized by public health leaders and regulators. This article describes public interest in CBD within the United States.
Theodore L. Caputi
Theodore L. Caputi
Economics & Health Researcher

My research interests include distributed robotics, mobile computing and programmable matter.